Cancer Letters
Volume 295, Issue 1 , Pages 17-26 , 1 September 2010

Therapeutic effect of MIP-1α-recruited dendritic cells on preestablished solid and metastatic tumors

  • Qi Cao

      Affiliations

    • Shanghai Institute of Immunology, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine (SJTUSM) and Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences & SJTUSM, Shanghai, China
    • Both authors contributed equally to this study.
    • ,
  • Yanliang Jin

      Affiliations

    • Shanghai Jiao Tong University School of Medicine, Affiliated Shanghai Children’s Medical Center, Shanghai, China
    • Both authors contributed equally to this study.
    • ,
  • Min Jin

      Affiliations

    • Shanghai Institute of Immunology, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine (SJTUSM) and Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences & SJTUSM, Shanghai, China
    • ,
  • Shan He

      Affiliations

    • Shanghai Institute of Immunology, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine (SJTUSM) and Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences & SJTUSM, Shanghai, China
    • ,
  • Qiaoli Gu

      Affiliations

    • The First Affiliated Hospital of Soochow University, Suzhou, China
    • ,
  • Songbing He

      Affiliations

    • The First Affiliated Hospital of Soochow University, Suzhou, China
    • ,
  • Yuhua Qiu

      Affiliations

    • Department of Immunology, Soochow University, Suzhou, China
    • ,
  • Hailiang Ge

      Affiliations

    • Shanghai Institute of Immunology, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine (SJTUSM) and Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences & SJTUSM, Shanghai, China
    • ,
  • Hiroyuki Yoneyama

      Affiliations

    • Department of Molecular Preventive Medicine, School of Medicine, The University of Tokyo, Tokyo, Japan
    • ,
  • Yanyun Zhang

      Affiliations

    • Shanghai Institute of Immunology, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine (SJTUSM) and Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences & SJTUSM, Shanghai, China
    • Corresponding Author InformationCorresponding author. Address: Shanghai Institute of Immunology, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine (SJTUSM) and Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences & SJTUSM, 227 South Chongqing Road, Shanghai 200025, China. Tel.: +86 21 63846590x776769; fax: +86 21 63852705.

Received 27 June 2008 ,Revised 5 February 2010 ,Accepted 10 February 2010.

References 

  1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245–252
  2. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 2006;311:17–58
  3. Timmerman JM, Levy R. Dendritic cell vaccines for cancer immunotherapy. Annu. Rev. Med. 1999;50:507–529
  4. Steinman RM, Pope M. Exploiting dendritic cells to improve vaccine efficacy. J. Clin. Invest. 2002;109:1519–1526
  5. O. Mazda, W.T.V. Germeraad, Tumor immunity and immuno gene therapy of cancer, in: O. Mazda (Ed.), Frontiers in Immuno-Gene Therapy, Research Signpost, Trivandrum, 2004, pp. 1–30.
  6. Hu J, Yuan X, Belladonna ML, Ong JM, Wachsmann-Hogiu S, Farkas DL, et al. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. Cancer Res. 2006;66:8887–8896
  7. Cho HI, Kim EK, Park SY, Lee SK, Hong YK, Kim TG. Enhanced induction of anti-tumor immunity in human and mouse by dendritic cells pulsed with recombinant TAT fused human survivin protein. Cancer Lett. 2007;258:189–198
  8. Nestle FO, Farkas A, Conrad C. Dendritic-cell-based therapeutic vaccination against cancer. Curr. Opin. Immunol. 2005;17:163–169
  9. Oh ST, Kim CH, Park MY, Won EH, Sohn HJ, Cho HI, et al. Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide. Vaccine. 2006;24:2860–2868
  10. Schmollinger JC, Vonderheide RH, Hoar KM, Maecker B, Schultze JL, Hodi FS, et al. Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction. Proc. Natl. Acad. Sci. 2003;100:3398–3403
  11. Brossart P, Brossart MDP. Dendritic cells in vaccination therapies of malignant diseases. Transfus. Apheresis. Sci. 2002;27:183–186
  12. Mackensen A, Herbst B, Chen JL, Kohler G, Noppen C, Herr W, et al. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells. Int. J. Cancer. 2000;86:385–392
  13. Zhang Y, Yoneyama H, Wang Y, Ishikawa S, Hashimoto S, Gao JL, et al. Mobilization of dendritic cell precursors into the circulation by administration of MIP-1alpha in mice. J. Natl. Cancer Inst. 2004;96:201–209
  14. Bueler H, Mulligan RC. Induction of antigenspecific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1. Mol. Med. 1996;2:545–555
  15. Reed DS, Romero P, Rimoldi D, Cerottini JC, Schaack J, Jongeneel CV. Construction and characterization of a recombinant adenovirus directing expression of the MAGE-1 tumor-specific antigen. Int. J. Cancer. 1997;72:1045–1055
  16. Zhang Y, Mukaida N, Wang J, Harada A, Akiyama M, Matsushima K. Induction of dendritic cell differentiation by granulocyte–macrophage colony-stimulating factor stem cell factor and tumor necrosis factor alpha in vitro from lineage phenotypes-negative c-kit murine hematopoietic progenitor cells. Blood. 1997;90:4842–4853
  17. Zhang Y, Harada A, Wang JB, Zhang YY, Hashimoto S, Naito M, et al. Bifurcated dendritic cell differentiation in vitro from murine lineage phenotype-negative c-kit+ bone marrow hematopoietic progenitor cells. Blood. 1998;92:118–128
  18. Yoneyama H, Matsuno K, Zhang Y, Murai M, Itakura M, Ishikawa S, et al. Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease. J. Exp. Med. 2001;193:35–49
  19. Yoneyama H, Harada A, Imai T, Baba M, Yoshie O, Zhang Y, et al. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. J. Clin. Invest. 1998;102:1933–1941
  20. Okada N, Mori N, Koretomo R, Okada Y, Nakayama T, Yoshie O, et al. Augmentation of the migratory ability of DC-based vaccine into regional lymph nodes by efficient CCR7 gene transduction. Gene Ther. 2005;12:129–139
  21. Lee AY, Chang SY, Kim JI, Cha HR, Jang MH, Yamamoto M, et al. Dendritic cells in colonic patches and iliac lymph nodes are essential in mucosal IgA induction following intrarectal administration via CCR7 interaction. Eur. J. Immunol. 2008;38:1127–1137
  22. Klein C, Bueler H, Mulligan RC. Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines. J. Exp. Med. 2000;191:1699–1708
  23. Schuler G, Steinman RM. Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med. 1997;186:1183–1187
  24. Itoh K, Hayashi A, Nakao M, Hoshino T, Seki N, Shichijo S. Human tumor rejection antigens MAGE. J. Biochem. 1996;119:385–390
  25. Lucas S, De Smet C, Arden KC, Viars CS, Lethe B, Lurquin C, et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res. 1998;58:743–752
  26. Tacken PJ, de Vries IJ, Torensma R, Figdor CG. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 2007;7:790–802
  27. Russo V, Cipponi A, Raccosta L, Rainelli C, Fontana R, Maggioni D, et al. Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity. J. Clin. Invest. 2007;117:3087–3096
  28. Germain RN, Margulies DH. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 1993;11:403–450
  29. Schnurr M, Galambos P, Scholz C, Then F, Dauer M, Endres S, et al. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines. Cancer Res. 2001;61:6445–6450
  30. S Diebold S, Cotten M, Koch N, Zenke M. MHC class II presentation of endogenously expressed antigens by transfected dendritic cells. Gene Ther. 2001;8:487–493
  31. Kaplan JM, Yu Q, Piraino ST, Pennington SE, Shankara S, Woodworth LA, et al. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens. J. Immunol. 1999;163:699–707
  32. Schumacher L, Ribas A, Dissette VB, McBride WH, Mukherji B, Economou JS, et al. Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses. J. Immunother. 2004;27:191–200
  33. Vulink A, Radford KJ, Melief C, Hart DN. Dendritic cells in cancer immunotherapy. Adv. Cancer Res. 2008;99:363–407
  34. Lopes L, Fletcher K, Ikeda Y, Collins M. Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategy. Cancer Immunol. Immunother. 2006;55:1011–1016
  35. Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 2005;5:296–306
  36. Reschner A, Hubert P, Delvenne P, Boniver J, Jacobs N. Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response. Clin. Exp. Immunol. 2008;152:219–226
  37. Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 1999;5:405–411
  38. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science. 2003;300:339–342
  39. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science. 2003;300:337–339
  40. Davila E, Kennedy R, Celis E. Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade. Cancer Res. 2003;63:3281–3288
  41. Adema GJ, de Vries IJ, Punt CJ, Figdor CG. Migration of dendritic cell based cancer vaccines: in vivo veritas?. Curr. Opin. Immunol. 2005;17:170–174
  42. Chen Z, Moyana T, Saxena A, Warrington R, Jia Z, Xiang J. Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells. Int. J. Cancer. 2001;93:539–548
  43. Eggert AA, Schreurs MW, Boerman OC, Oyen WJ, de Boer AJ, Punt CJ, et al. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res. 1999;59:3340–3345
  44. Smith AL, Fazekas de St Groth B. Antigen-pulsed CD8α dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node. J. Exp. Med. 1999;189:593–598
  45. Morse MA, Coleman RE, Akabani G, Niehaus N, Coleman D, Lyerly HK. Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res. 1999;59:56–58
  46. Yoneyama H, Narumi S, Zhang Y, Murai M, Baggiolini M, Lanzavecchia A, et al. Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J. Exp. Med. 2002;195:1257–1266

PII: S0304-3835(10)00097-2

doi: 10.1016/j.canlet.2010.02.009

Cancer Letters
Volume 295, Issue 1 , Pages 17-26 , 1 September 2010

Article Tools

* Image Usage & Resolution